crs-207
Showing 1 - 5 of 5
Metastatic Pancreatic Adenocarcinoma Trial in Baltimore (Epacadostat, Pembrolizumab, CRS-207)
Active, not recruiting
- Metastatic Pancreatic Adenocarcinoma
- Epacadostat
- +4 more
-
Baltimore, MarylandThe Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Jan 3, 2023
Pancreatic Cancer Trial in Baltimore (Tadalafil, Pembrolizumab, Ipilimumab)
Recruiting
- Pancreatic Cancer
- Tadalafil
- +3 more
-
Baltimore, MarylandSidney Kimmel Comprehensive Cancer Center
Aug 23, 2022
Previously Treated Metastatic Adenocarcinoma of the Pancreas Trial in United States (CRS-207, nivolumab, GVAX)
Completed
- Previously Treated Metastatic Adenocarcinoma of the Pancreas
- CRS-207
- +3 more
-
San Francisco, California
- +4 more
Mar 17, 2021
Platinum-resistant Ovarian Cancer, Platinum-resistant Fallopian Cancer, Platinum-resistant Peritoneal Cancer Trial in Canada,
Terminated
- Platinum-resistant Ovarian Cancer
- +2 more
- CRS-207
- +2 more
-
Scottsdale, Arizona
- +11 more
Apr 1, 2019
Metastatic Pancreatic Cancer Trial in United States (GVAX Pancreas, CRS-207, Cyclophosphamide)
Completed
- Metastatic Pancreatic Cancer
- GVAX Pancreas
- +2 more
-
Tampa, Florida
- +9 more
Apr 6, 2018